A case report from a New Jersey hospital highlights how drug-resistant pathogens can take advantage of COVID-related disruptions to standard infection and prevention control (IPC) practices.In a paper published yesterday in Morbidity and Mortality Weekly Report, researchers from the Centers for Disease Control and Prevention (CDC), the New Jersey Department of Health (NJDOH), and Rutgers University report on an outbreak of carbapenem-resistant Acinetobacter baumannii (CRAB) at an unnamed 500-bed hospital that occurred during the spring surge of coronavirus infections in the state.A total of 34 patients were found to be infected or colonized with the multidrug-resistant pathogen, which frequently contaminates healthcare surfaces and is